AstraZeneca drops development of key stroke drug
(AFP)


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/afp/20061026/hl_afp/britainswedenpharmahealthcompanyproductastrazeneca"><img src="http://d.yimg.com/us.yimg.com/p/afp/20061026/capt.sge.fpe50.261006101602.photo00.photo.default-512x333.jpg?x=130&y=84&sig=_Tw9pE78ZiE0CLhXfKQBhA--" align="left" height="84" width="130" alt="Indian scientists work in the Bangalore laboratory of Anglo-Swedish pharmaceuticals giant AstraZeneca, June 2003. AstraZeneca has announced it has ended development of a drug for reducing disability caused by strokes because the product had failed the final stages of clinical trials.(AFP/File/Indranil Mukherjee)" border="0" /></a>AFP - Anglo-Swedish pharmaceuticals giant AstraZeneca has said that it has ended development of a drug for reducing disability caused by strokes because the product had failed the final stages of clinical trials.</p><br clear="all"/>